Alebund Pharmaceuticals is an integrated biopharmaceutical company dedicated to developing innovative therapies for renal diseases and related chronic conditions. The company focuses on advancing its pipeline of treatments, including a best-in-class iron-based phosphate binder and a first-in-class pan phosphate transporter inhibitor, while also expanding the commercial reach of its products in China and globally.
Leadership & Board
Key Executives
Co-Founder and Chief Medical OfficerJin Tian
Co-Founder and Chief Executive OfficerGavin Xia
Current Number of Employees14
Current LinkedIn Followers144
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$550M
Total Amount Raised$550M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$550M
Latest Funding Amount$550M
Latest Funding RoundSeries C
Latest Funding RoundSeries C
Post-Money Valuation―
Post-Money Valuation―
Employee Trend
Alebund Pharmaceuticals had 14 employees as of May 18, 2026. The number of employees increased by 0 (0.00%) week-over-week.
14Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
Alebund Pharmaceuticals had 144 followers as of May 18, 2026. The number of followers increased by 5 (3.60%) week-over-week.
144Latest Followers Count
5(3.60%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.